Dr Peter Kennerley,
AgosPharma CEO
VasoDynamics Medical Monitor

Peter has a wealth of experience as a Medical Adviser in the pharmaceutical industry, including spells at Astra, Janssen-Cilag and Johnson & Johnson and has overseen the development of many medicinal products, from blockbusters to niche products. Peter was a former Senior Medical Assessor for the UK Regulatory Agency, has established global drug safety processes and has extensive experience in negotiations with European regulatory authorities

Professor Kairbaan Hodivala-Dilke,
Deputy Institute Director, Professor of the Tumour Microenvironment at Barts Cancer Institute,
VasoDynamics Scientific Adviser

Kairbaan Hodivala-Dilke started undergraduate studies at the University of Southampton, gaining a PhD after studying epithelial cell biology with Professor Fiona Watt at The Imperial Cancer Research Fund. Hodivala-Dilke undertook postdoctoral work with Professor Richard Hynes at The Massachusetts Institute of Technology, USA, where her experience in using genetically modified mice began. She then returned to the UK and was an Imperial Cancer Research Fund tenure-track fellow with Professor Ian Hart, first at St. Thomas’ Hospital and later at Barts Cancer Institute, Barts and The London School of Medicine and Dentistry. She was awarded tenure in 2004 and became Professor of Angiogenesis in 2009 and has been Deputy Director of the Barts Cancer Institute since 2012.

Dr Mary Lei,
Consultant clinical oncologist at Guy’s Cancer, Guy’s and St Thomas’ NHS Foundation Trust & Honorary senior lecturer, Faculty of Life Sciences and Medicine, King’s College London
VasoDynamics Chief Investigator

Dr Lei is a consultant clinical oncologist at Guy’s Cancer. She graduated from King’s College London and undertook specialist training in London. After completing a postgraduate research MD degree at the University of Surrey evaluating image-guided intensity modulated radiotherapy (IMRT) in head and neck cancer, she undertook a one year IMRT fellowship at Guy’s Cancer. She was appointed as a consultant at Guy’s in 2011. Her special interests include head and neck, thyroid and neuroendocrine tumours. Dr Lei leads a research programme in head and neck cancer survivorship and supervises a number of MD and PhD research fellows at KCL.

Dr Barry Quinn,
Senior Lecturer/Associate Professor, Cancer
and Palliative Care, Queen’s University
Belfast, MBRU, Dubai
VasoDynamics Clinical Adviser

Barry has worked in the field of cancer and palliative care for over 30 years as a clinician, researcher, educator and writer. Alongside his clinical and teaching commitments, he is Chair of the European expert group ‘Managing Advanced Cancer Pain Together’ (MACPT), exploring ways to better manage pain in the advanced cancer setting. Heis a founding member of the UK Oral Management in Cancer Group (UKOMiC) and is the Chair of the ‘European Oral Care in Cancer’ (EOCC) Group, a multi-professional group of practitioners working in the field of cancer with a focus on addressing oral complications arising from malignant disease and treatment. Barry continues to focus on addressing the side effects of cancer treatments and advancing disease. He writes extensively for nursing and health care journals.

Dr Rafael Moleron, 
Consultant Clinical Oncologist, Aberdeen
Royal Infirmary
VasoDynamics Medical Adviser

Dr Moleron graduated from the University of Granada in 2003 and completed his training as a clinical oncologist in Hospital Puerta de Hierro in Madrid in 2008. He then underwent doctoral studies at the Universidad Autonoma de Madrid. He worked as a consultant in Hospital Ramon y Cajal and Hospital Puerta de Hierro-Majadahonda (Spain). Since 2014, Dr Moleron has been a consultant clinical oncologist subspecialising in head and neck cancer and neuro-oncology at Aberdeen Royal Infirmary and from April 2017 he has been service Clinical Director for Oncology. Dr Moleron has a special interest in advanced radiotherapy techniques and clinical research.

Professor Shah-Jalal Sarker
Honorary Associate Professor, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences
VasoDynamics Statistical Adviser

Dr Shah-Jalal Sarker is an Associate Professor of Medical Statistics & Epidemiology at the Institute of Neurology at University College, London. Shah-Jalal holds a PhD in Statistics (2002) from the University of Surrey and an MSc in Epidemiology (1998) from the Erasmus University Rotterdam (jointly with the University of Cambridge). His BSc (First Class Honours) and MSc (First Class, 1995) were in Statistics. In 2012, he obtained “Postgraduate Certificate in Academic Practice (PGCAP)” with Distinction from the University of London and became a Fellow of the Higher Education Academy.
He is an experienced quantitative (Biostatistics and Epidemiology) researcher with professional recognition for teaching statistics to non-statisticians. He works as an Educator, Clinical Trial Statistician, Inter-disciplinary Collaborative Researcher and Statistical Consultant. He is a reviewer for NIHR program grant for applied research including several international journals (e.g. BMJ open, PLOS One) and member of several reputable international statistical professional societies (e.g. Royal Statistical Society, Statisticians in the Pharmaceutical Industry, Society for Clinical Trials, International Society for Clinical Biostatistics).

Key
Management

We are a pharmaceutical development company
with experienced executives and a shared vision
to improve the standard of cancer care.

Dr Peter Kennerley,
AgosPharma CEO
VasoDynamics Medical Monitor

Peter has a wealth of experience as a Medical Adviser in the pharmaceutical industry, including spells at Astra, Janssen-Cilag and Johnson & Johnson and has overseen the development of many medicinal products, from blockbusters to niche products. Peter was a former Senior Medical Assessor for the UK Regulatory Agency, has established global drug safety processes and has extensive experience in negotiations with European regulatory authorities

Professor Kairbaan Hodivala-Dilke,
Deputy Institute Director, Professor of the Tumour Microenvironment at Barts Cancer Institute,
VasoDynamics Scientific Adviser

Kairbaan Hodivala-Dilke started undergraduate studies at the University of Southampton, gaining a PhD after studying epithelial cell biology with Professor Fiona Watt at The Imperial Cancer Research Fund. Hodivala-Dilke undertook postdoctoral work with Professor Richard Hynes at The Massachusetts Institute of Technology, USA, where her experience in using genetically modified mice began. She then returned to the UK and was an Imperial Cancer Research Fund tenure-track fellow with Professor Ian Hart, first at St. Thomas’ Hospital and later at Barts Cancer Institute, Barts and The London School of Medicine and Dentistry. She was awarded tenure in 2004 and became Professor of Angiogenesis in 2009 and has been Deputy Director of the Barts Cancer Institute since 2012.

Dr Mary Lei,
Consultant clinical oncologist at Guy’s Cancer, Guy’s and St Thomas’ NHS Foundation Trust & Honorary senior lecturer, Faculty of Life Sciences and Medicine, King’s College London
VasoDynamics Chief Investigator

Dr Lei is a consultant clinical oncologist at Guy’s Cancer. She graduated from King’s College London and undertook specialist training in London. After completing a postgraduate research MD degree at the University of Surrey evaluating image-guided intensity modulated radiotherapy (IMRT) in head and neck cancer, she undertook a one year IMRT fellowship at Guy’s Cancer. She was appointed as a consultant at Guy’s in 2011. Her special interests include head and neck, thyroid and neuroendocrine tumours. Dr Lei leads a research programme in head and neck cancer survivorship and supervises a number of MD and PhD research fellows at KCL.

Dr Barry Quinn,
Senior Lecturer/Associate Professor, Cancer
and Palliative Care, Queen’s University
Belfast, MBRU, Dubai
VasoDynamics Clinical Adviser

Barry has worked in the field of cancer and palliative care for over 30 years as a clinician, researcher, educator and writer. Alongside his clinical and teaching commitments, he is Chair of the European expert group ‘Managing Advanced Cancer Pain Together’ (MACPT), exploring ways to better manage pain in the advanced cancer setting. Heis a founding member of the UK Oral Management in Cancer Group (UKOMiC) and is the Chair of the ‘European Oral Care in Cancer’ (EOCC) Group, a multi-professional group of practitioners working in the field of cancer with a focus on addressing oral complications arising from malignant disease and treatment. Barry continues to focus on addressing the side effects of cancer treatments and advancing disease. He writes extensively for nursing and health care journals.

Dr Rafael Molero, 
Consultant Clinical Oncologist, Aberdeen
Royal Infirmary
VasoDynamics Medical Adviser

Dr Moleron graduated from the University of Granada in 2003 and completed his training as a clinical oncologist in Hospital Puerta de Hierro in Madrid in 2008. He then underwent doctoral studies at the Universidad Autonoma de Madrid. He worked as a consultant in Hospital Ramon y Cajal and Hospital Puerta de Hierro-Majadahonda (Spain). Since 2014, Dr Moleron has been a consultant clinical oncologist subspecialising in head and neck cancer and neuro-oncology at Aberdeen Royal Infirmary and from April 2017 he has been service Clinical Director for Oncology. Dr Moleron has a special interest in advanced radiotherapy techniques and clinical research.

Professor Shah-Jalal Sarker
Honorary Associate Professor, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences
VasoDynamics Statistical Adviser

Dr Shah-Jalal Sarker is an Associate Professor of Medical Statistics & Epidemiology at the Institute of Neurology at University College, London. Shah-Jalal holds a PhD in Statistics (2002) from the University of Surrey and an MSc in Epidemiology (1998) from the Erasmus University Rotterdam (jointly with the University of Cambridge). His BSc (First Class Honours) and MSc (First Class, 1995) were in Statistics. In 2012, he obtained “Postgraduate Certificate in Academic Practice (PGCAP)” with Distinction from the University of London and became a Fellow of the Higher Education Academy.
He is an experienced quantitative (Biostatistics and Epidemiology) researcher with professional recognition for teaching statistics to non-statisticians. He works as an Educator, Clinical Trial Statistician, Inter-disciplinary Collaborative Researcher and Statistical Consultant. He is a reviewer for NIHR program grant for applied research including several international journals (e.g. BMJ open, PLOS One) and member of several reputable international statistical professional societies (e.g. Royal Statistical Society, Statisticians in the Pharmaceutical Industry, Society for Clinical Trials, International Society for Clinical Biostatistics).